Here's Why Hims & Hers Health, Inc. (HIMS) Fell More Than Broader Market

Core Insights - Hims & Hers Health, Inc. (HIMS) experienced a decline of 5.75% in its stock price, underperforming compared to the S&P 500's loss of 0.63% [1] - The company has shown a significant increase of 24.65% in its stock price over the past month, outperforming the Medical sector and the S&P 500 [1] Earnings Forecast - The upcoming earnings report is scheduled for November 3, 2025, with an expected EPS of $0.09, indicating a 50% increase from the same quarter last year [2] - Revenue is projected to reach $581.61 million, reflecting a 44.84% rise compared to the equivalent quarter last year [2] Annual Estimates - For the entire year, the Zacks Consensus Estimates predict earnings of $0.6 per share and revenue of $2.35 billion, representing increases of 122.22% and 59.03% respectively from the previous year [3] Analyst Estimates - Recent adjustments to analyst estimates for Hims & Hers Health, Inc. are crucial as they reflect short-term business trends and analysts' confidence in the company's performance [4] Zacks Rank and Performance - The Zacks Rank system currently rates Hims & Hers Health, Inc. at 4 (Sell), with a recent decline of 0.28% in the consensus EPS estimate [6] - Historically, stocks rated 1 (Strong Buy) have delivered an average annual return of +25% since 1988 [6] Valuation Metrics - Hims & Hers Health, Inc. has a Forward P/E ratio of 105.22, significantly higher than the industry average of 40.64, indicating a premium valuation [7] - The company also has a PEG ratio of 4.29, compared to the industry average of 3.33, suggesting higher anticipated earnings growth relative to its price [8] Industry Context - The Medical Info Systems industry, to which Hims & Hers belongs, has a Zacks Industry Rank of 93, placing it in the top 38% of over 250 industries [8] - The Zacks Industry Rank indicates that the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [9]